OPS | Bigg Rec

Résultats : 1 - 10 sur 2,084

Résultats : 1 - 10 sur 2,084

WHO suggests for patients with suspected or confirmed filovirus disease and clinical signs of shock or circulatory impairment, the serial measurement of lactate as part of the assessment of perfusion to guide further intravenous fluid management.

Année: 2026

Institution: Non disponible

Recommandé en faveur

Conditionnelle

Certitude des données probantes

Faible

WHO suggests against the use of tranexamic acid in patients with confirmed filovirus disease and haemorrhage.

Année: 2026

Institution: Non disponible

Recommandé contre

Conditionnelle

Certitude des données probantes

Très faible

WHO recommends that for patients with suspected or confirmed filovirus disease requiring central venous access, ultrasound guided placement be used rather than non-ultrasound guided placement.

Année: 2026

Institution: Non disponible

Recommandé en faveur

Forte

Certitude des données probantes

Modérée

WHO suggests for the use of presumptive broad-spectrum antibiotics in patients with confirmed filovirus disease in the presence of suspected sepsis or bacterial co-infection.

Année: 2026

Institution: Non disponible

Recommandé en faveur

Conditionnelle

Certitude des données probantes

Faible

WHO recommends that Ervebo® should not be used outside of controlled research settings in response to the current Bundibugyo virus ( BDBV ) outbreak.

Année: 2026

Institution: Non disponible

Recommandation en contexte de recherche

Uniquement dans des contextes de recherche

Certitude des données probantes

Très faible

WHO suggests for the use of tranexamic acid in patients with confirmed filovirus disease and postpartum haemorrhage.

Année: 2026

Institution: Non disponible

Recommandé en faveur

Conditionnelle

Certitude des données probantes

Faible

WHO suggests for patients with suspected or confirmed filovirus disease and clinical signs of shock or circulatory impairment, capillary refill time should be used as part of the assessment of perfusion to guide intravenous fluid management

Année: 2026

Institution: Non disponible

Recommandé en faveur

Conditionnelle

Certitude des données probantes

Faible

WHO recommends that for patients with suspected or confirmed filovirus disease, systematic laboratory monitoring be performed based on clinical assessment, rather than on routine testing.

Année: 2026

Institution: Non disponible

Recommandé en faveur

Forte

Certitude des données probantes

Faible

WHO suggests against mass testing in community settings to reduce the transmission of influenza viruses during influenza epidemics and pandemics.

Année: 2026

Institution: World Health Organization

Recommandé contre

Conditionnelle

Certitude des données probantes

Très faible

WHO suggests against travel restrictions (including border closures) to reduce the transmission of influenza viruses in the community during influenza epidemics and pandemics.

Année: 2026

Institution: World Health Organization

Recommandé contre

Conditionnelle

Certitude des données probantes

Très faible